Trauma Fixation Devices Market

Market Overview

The global trauma fixation devices market size was valued at USD 8.37 billion in 2022. It is projected to reach USD 17.73 billion by 2031, growing with a CAGR of 8.7% during the forecast period (2023–2031).

Trauma is any type of externally-caused physical harm, including fractures, dislocations, sprains and strains, and burns. Depending on the degree of the damage, trauma fixation devices are one of the clinical procedures utilized in trauma care. These instruments are utilized primarily for lengthy bone fractures. Other locations addressed by the trauma devices include the upper and lower extremities, including the knee, joint, leg, and spine. In addition, there is a shift toward polymeric materials in trauma devices for improved outcomes. These mostly consist of bone fixation components like screws and plates.

Trauma fixation devices are an essential, first-line treatment for bone fractures and tissue degeneration. Although trauma fixation devices have been in use for decades, they are always being improved. Enhancing device engineering with high-performance polymers is perhaps the most potential advancement route. Companies are creating technologically sophisticated devices to meet the rising demand for trauma fixation devices and to expand their market share. Technologically enhanced products, such as drug-eluting implants, bioresorbable implants, and nanocoated devices, have considerably increased the use of trauma fixation devices in hospitals and surgery centers. In terms of technology and user-friendliness, trauma fixation devices have experienced revolutionary developments, which have fueled market expansion.

Market Dynamics

Global Trauma Fixation Devices Market Drivers

Rising Number of Accidents

The market for trauma fixation devices is anticipated to be propelled by the rising rate of vehicle accidents. According to the World Health Organization, over 1.25 million deaths occur yearly as a result of road traffic accidents and collisions. Injuries that do not result in death affect an additional 20 to 50 million people, with many sustaining physical disabilities. It has been found that in a severe car crash, more than 20% of people suffer from head and chest injuries. Therefore, vehicle traffic accidents are one of the top causes of mortality and disability worldwide.

Technological Development

Technology advancements in trauma fixation devices give people more mobility, dexterity, and functional abilities. These developments have reduced the necessity for removal surgery as well as long-term interference with bones, muscles, and tendons. The commercialization of improved technology-based trauma fixation devices has boosted their demand among customers; consequently, technological progress is driving market demand. Bioresorbable implants and nanocoated devices, among other technologically advanced products, drive greater demand for trauma fixation devices. In June 2020, Depuy Synthes, a subsidiary of Johnson & Johnson, released Dynacord Suture in several European territories. The suture is intended for soft tissue approximation and rotator cuff repairs.

Global Trauma Fixation Devices Market Restraints

Health Complications

The numerous hazards and health issues connected with trauma fixation devices, as well as the requirement for additional surgical intervention to correct some of them, are anticipated to impede the market demand for these products. Common fixator problems include pin-site infections and pin loosening. Other less frequent consequences include neurovascular damage, mechanical failure, septic joint, pin tract osteomyelitis, and over-insertion of the needle. Consequently, the health concerns associated with trauma fixation devices are anticipated to restrain the growth of the global market for trauma fixation.

Regional Analysis

The global trauma fixation devices market is segmented by the Americas, Asia Pacific, Europe, the Middle East, and Africa.

North America dominates the global trauma fixation devices market due to increasing road accidents. Around 37,000 people die, and 2.35 million are injured or disabled because of accidents in the U.S. annually, according to the Association for Safe International Road Travel. As a result, the demand for trauma fixation devices has increased. The prevalence of degenerative bone diseases will also impact the growth of the U.S. market for trauma fixation devices. Degenerative bone disease is an illness that causes inflammation and structural joint deterioration. According to the Centers for Disease Control and Prevention, more than 50 percent of persons aged 65 and older in the United States suffer from degenerative bone disease. By 2040, the CDC projects that around 78 million (26%) U.S. persons aged 18 or older will have been diagnosed with arthritis. This disease's high prevalence will raise product demand. Additionally, the swift and well-established healthcare services and infrastructure contribute to the expansion of the regional market for trauma fixation devices. In addition, the presence of important competitors in the region and the presence of supported reimbursement programs provide enormous potential opportunities for the market.

In Europe, the rise in prevalence and incidence of bone fractures, a growing elderly population, and a wide range of solutions offered by industry participants are the primary factors driving the future growth of the trauma fixation market. There is a rise in the incidence of hip fractures and other bone problems, such as osteoporosis, due to the aging of the population. In addition, the growth in traffic accidents raises the market demand for these gadgets. However, negative effects from the materials employed in the devices or mishandling or misplacing by inexperienced medical workers inhibit the development of trauma fixation devices. The rising prevalence of musculoskeletal disorders mostly drives the market for trauma fixation devices in the United Kingdom.

Asia Pacific is the emerging trauma fixation devices market and will likely witness significant growth during the forecast period. Moreover, this region has poor infrastructural development, leading to increased casualties. For instance, over 80% of road fatalities happen in developing countries and cost around USD 65 billion annually, according to the  Association for Safe International Road Travel. The increasing number of cars and drivers combined with narrow roads and heavy traffic leads to casualties. India and China are known for their deadly heavy traffics. Increasing investment in building national highways paves the way for better fatality management in developing countries. Higher awareness of enhanced internal trauma fixation devices, rising healthcare costs, improving economic conditions, and technological advancements are anticipated to drive the market throughout the forecast period.

Middle East and Africa are on the verge of economic development, leading to a lucrative growth opportunity in the region. In the last few years, Africa and the middle east have been at the topmost position for the highest number of road fatalities. Increasing incidences of road accidents and injuries in the Middle East and Africa area, the rising elderly population, and the growing use of minimally invasive surgical treatments all contribute to the expansion of the market. As per the WHO, low-income countries have an average of 27.5 deaths per 100,000, thrice that of developed countries. Increasing incidence and complexity of fractures, limited healthcare facilities such as inadequate operating theatre facilities, lack of equipment, lack of expertise, long distances to a healthcare facility, and patient ignorance are obstacles to effective fracture management in developing nations of Latin America. South America needs an upgrade in infrastructure. Over 60% of regions’ roads are underdeveloped, leading to increased road accidents.

Segmental Analysis

The trauma fixation devices market can be segmented by type, surgical site, and end-user.

By type, the global market is segmented into internal fixators and external fixators.

The internal fixators segment accounts for the largest share of the market. Currently, advancements in internal fixators are having the edge over external fixators as they are more durable, heal faster, and provide better support to the bones. Materials used for these have an extensive range from stainless steel to titanium. Moreover, advanced materials like biopolymers are offering a turnkey platform to manufacturers. For instance, Invibio designs and manufactures high-trauma implants.

By surgical site, the global market is segmented into upper extremities and lower extremities.

The Lower Extremity has the biggest market share. The lower extremity consists of the foot and ankle, thigh, hip and pelvis, lower leg, and knee. The increase results from the rising incidence of bone-related injuries, traumatic accidents, and osteoporosis.

Based on End-user, the market is segmented into hospitals and ambulatory surgical centers.

Ambulatory surgical centers are growing at a significant CAGR in the forecast period as they provide low-cost surgical procedures and same-day discharge for minor surgery. The popularity of ambulatory surgical centers is increasing in healthcare facilities, and significant growth can be seen in this segment. For instance, the number of ASCs has doubled since 2000 in the U.S.

Recent Developments

• August 2021- During the annual conference of the American Academy of Orthopaedic Surgeons (AAOS) in San Diego, DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, showcased new products and technological solutions that are establishing new standards of care for modern orthopedics. DePuy Synthes displayed next-generation product innovations for its Digital Surgery, Hip, Knee, Shoulder, Trauma and Extremities, Spine, Sports Medicine, and Power Tools portfolios, including robotics and more personalized implants, connected instrumentation, advanced imaging, and visualization technology.
• February 2021- Zimmer Biomet Holdings, Inc., a global pioneer in musculoskeletal healthcare, announced its plan to spin off the Company's Spine and Dental operations to become a new, publicly traded company ("NewCo"). Both Zimmer Biomet and NewCo will be better able to address the demands of patients and customers as a result of the planned arrangement, which is anticipated to result in faster growth and more value for all stakeholders.